In addition, Navitoclax diminished the secretion of many factors from senescent murine lungs, such as p16INK4A and TNFα, and it also lowered the risk of post-traumatic osteoarthritis by selectively eliminating senescent cells from the articular cartilage and synovial membrane [10]. This evidence concerns the gene CDKN2A and osteoarthritis.